- Home
- TRS vs VRDN Comparison
TRS vs VRDN Comparison
Compare TRS & VRDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRS
- VRDN
- Stock Information
- Founded
- TRS 1986
- VRDN 2006
- Country
- TRS United States
- VRDN United States
- Employees
- TRS N/A
- VRDN N/A
- Industry
- TRS Industrial Specialties
- VRDN Medical Specialities
- Sector
- TRS Industrials
- VRDN Health Care
- Exchange
- TRS Nasdaq
- VRDN Nasdaq
- Market Cap
- TRS 1.5B
- VRDN 1.5B
- IPO Year
- TRS 2007
- VRDN N/A
- Fundamental
- Price
- TRS $38.33
- VRDN $19.23
- Analyst Decision
- TRS Strong Buy
- VRDN Strong Buy
- Analyst Count
- TRS 2
- VRDN 11
- Target Price
- TRS $45.00
- VRDN $38.80
- AVG Volume (30 Days)
- TRS 623.2K
- VRDN 881.3K
- Earning Date
- TRS 07-29-2025
- VRDN 08-06-2025
- Dividend Yield
- TRS 0.42%
- VRDN N/A
- EPS Growth
- TRS N/A
- VRDN N/A
- EPS
- TRS 0.91
- VRDN N/A
- Revenue
- TRS $973,840,000.00
- VRDN $305,000.00
- Revenue This Year
- TRS $6.37
- VRDN N/A
- Revenue Next Year
- TRS $5.49
- VRDN $17,102.33
- P/E Ratio
- TRS $41.42
- VRDN N/A
- Revenue Growth
- TRS 6.72
- VRDN 5.90
- 52 Week Low
- TRS $19.33
- VRDN $9.90
- 52 Week High
- TRS $38.53
- VRDN $27.20
- Technical
- Relative Strength Index (RSI)
- TRS 77.16
- VRDN 64.35
- Support Level
- TRS $36.36
- VRDN $17.04
- Resistance Level
- TRS $37.49
- VRDN $18.39
- Average True Range (ATR)
- TRS 0.83
- VRDN 1.10
- MACD
- TRS 0.01
- VRDN 0.05
- Stochastic Oscillator
- TRS 94.39
- VRDN 90.43
About TRS TriMas Corporation
TriMas Corp designs, develops and manufactures a diverse set of products primarily for the consumer products, aerospace & defense, and industrial markets . The company operates through three segments namely: The packaging segment manufactures and distributes closure and dispensing systems. The aerospace segment supplies blind bolts, fasteners, rivets, and other products for the aerospace industry. The specialty product segment manufactures and distributes steel cylinders, wellhead engines, compression systems, industrial sealing, and fasteners.
About VRDN Viridian Therapeutics Inc.
Viridian Therapeutics Inc is a clinical-stage biopharmaceutical company that engages in developing multiple product candidates to treat patients who suffer from thyroid eye disease. Its product candidate includes Veligrotug (formerly known as VRDN-001) for intravenous (IV) and VRDN-003 for subcutaneous (SC) administration. Veligrotug is a differentiated humanized monoclonal antibody targeting IGF-1R intravenously administered for the treatment of thyroid eye disease (TED).